Filing Details
- Accession Number:
- 0001033905-18-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-25 12:26:49
- Reporting Period:
- 2018-06-22
- Accepted Time:
- 2018-06-25 12:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1033905 | Luminex Corp | LMNX | Surgical & Medical Instruments & Apparatus (3841) | 742747608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1105966 | Ii Walter G Loewenbaum | 12212 Technology Boulevard Austin TX 78727 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-06-22 | 40,797 | $31.03 | 491,151 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 909,415 | Indirect | Spouse |
Common Stock | 96,614 | Indirect | Partnership |
Common Stock | 428,520 | Indirect | Trusts |
Common Stock | 45,000 | Indirect | Limited Liability Company |
Footnotes
- This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 previously adopted by the seller. The representation regarding the seller's knowledge of material adverse non-public information speaks to the aforementioned trading plan adopted.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $31.14 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.